Myosin light-chain phosphorylation controls insulin secretion at a proximal step in the secretory cascade

Am J Physiol. 1997 Oct;273(4):E782-9. doi: 10.1152/ajpendo.1997.273.4.E782.

Abstract

The aim of this study was to investigate how insulin secretion is controlled by phosphorylation of the myosin light chain (MLC). Ca2+-evoked insulin release from pancreatic islets permeabilized with streptolysin O was inhibited by different monoclonal antibodies against myosin light-chain kinase (MLCK) to an extent parallel to their inhibition of purified MLCK. Anti-MLCK antibody also inhibited insulin release caused by the stable GTP analog guanosine 5'-O-(3-thiodiphosphate), even at a substimulatory concentration (0.1 microM) of Ca2+. Free Ca2+ increased MLC peptide phosphorylation by beta-cell extracts in vitro. In contrast to the phosphorylation by purified MLCK or by calmodulin (CaM) kinase II, the activity partially remained with the beta-cell under nonstimulatory Ca2+ (0.1 microM) conditions. The MLCK inhibitor ML-9 inhibited the activity in the beta-cell with both substimulatory and stimulatory Ca2+, whereas KN-62, an inhibitor of CaM kinase II, only exerted an influence in the latter case. ML-9 decreased intracellular granule movement in MIN6 cells under basal and acetylcholine-stimulated conditions. We propose that MLC phosphorylation may modulate translocation of secretory granules, resulting in enhanced insulin secretion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Azepines / pharmacology
  • Bacterial Proteins
  • Calcium / pharmacology*
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
  • Cell Membrane Permeability
  • Cells, Cultured
  • Enzyme Inhibitors / pharmacology
  • Guanosine 5'-O-(3-Thiotriphosphate) / pharmacology
  • Homeostasis
  • Insulin / metabolism*
  • Insulin Secretion
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism
  • Islets of Langerhans / physiology*
  • Kinetics
  • Male
  • Myosin Heavy Chains / metabolism
  • Myosin Light Chains / metabolism*
  • Myosin-Light-Chain Kinase / immunology
  • Myosin-Light-Chain Kinase / metabolism*
  • Phosphorylation
  • Rats
  • Rats, Wistar
  • Streptolysins

Substances

  • Antibodies, Monoclonal
  • Azepines
  • Bacterial Proteins
  • Enzyme Inhibitors
  • Insulin
  • Myosin Light Chains
  • Streptolysins
  • streptolysin O
  • ML 9
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • KN 62
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Myosin-Light-Chain Kinase
  • Myosin Heavy Chains
  • Calcium